Meet Our Team

Accomplished. Experienced.

Leadership Team

  • Eric B. Kmiec, Ph.D.

    Founder & Chief Executive Officer

    Bio

  • Jan Case

    Chief Operating Officer

    Bio

  • Jon Brilliant

    Chief Financial Officer

    Bio

  • Michael Alexander, Ph.D.

    General Counsel

    BIO

Board of Directors

  • Janice E. Nevin, MD, MPH

    Janice E. Nevin, M.D.

    Board Chair
    President & CEO, ChristianaCare

    Bio

  • Jeffrey Carper

    Entrepreneur and Investor
    Co-Founder, Gentas Biotechnology

    Bio

  • Jill Castilla

    Chair, President & CEO
    Citizens Bank of Edmond

    Bio

  • Eric B. Kmiec, Ph.D.

    Founder & CEO
    CorriXR Therapeutics, Inc.

    BIO

Clinical and Scientific Advisors

  • Bhisham Chera, M.D., FASTRO

    Endowed Chair in Radiation Oncology
    Hollings Cancer Center
    Medical University of South Carolina

    BIO

  • Robert L. Ferris, M.D., Ph.D.

    Executive Director,
    Lineberger Comprehensive Cancer Center
    University of North Carolina

    BIO

  • Glenn J. Hanna, M.D.

    Director, Center for Cancer Therapeutic Innovation
    Dana-Farber Cancer Institute
    Harvard Medical School

    BIO

  • Neil Hockstein, M.D.

    Director of Head and Neck Multidisciplinary Care,
    Helen F. Graham Cancer Center & Research Institute
    ChristianaCare

    BIO

  • Mark Behlke, M.D., Ph.D.

    Chief Scientific Officer
    IDT

    Bio

  • Zhi Chen, Ph.D.

    Co-Founder & CEO
    Gentas Biotechnology

    Bio

  • Nicholas J. Petrelli, M.D., FACS

    Director, Cawley Center for Translational Cancer Research
    Helen F. Graham Cancer Center & Research Institute, ChristianaCare

    BIO

  • Gregory J. Tiesi, M.D.

    Chief of Surgical Oncology: Southern Region
    Medical Director of Hepatobiliary Surgery, Hackensack Meridian Jersey Shore University Medical Center

    Bio

ChristianaCare Gene Editing Institute

CorriXR is the inaugural biotech spin-out of ChristianaCare, a large healthcare system, and the Gene Editing Institute, which has been embedded in ChristianaCare’s Helen F. Graham Cancer Center & Research Institute since 2015. This unique collaboration provides direct access to oncologists, researchers and patient populations — de-risking clinical translation and speeding time to market.

The Gene Editing Institute is CorriXR’s unmatched research and development engine. These scientists bring decades of gene editing research and technology development experience and support including:

  • PDX and PDC mouse model validation

  • Critical in vivo studies

  • Cell model development and refinement

  • Next Generation Sequencing (NGS) capabilities and advanced analytics

MORE ON GEI

Our Research

Learn more about our recent scientific publications

Publications